0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.70%
Revenue growth 1.25-1.5x 3606.HK's 12.93%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
15.77%
Gross profit growth above 1.5x 3606.HK's 10.37%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
105.96%
EBIT growth above 1.5x 3606.HK's 15.57%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
105.96%
Operating income growth above 1.5x 3606.HK's 19.36%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
322.84%
Net income growth above 1.5x 3606.HK's 21.88%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
330.00%
EPS growth above 1.5x 3606.HK's 20.83%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
344.83%
Diluted EPS growth above 1.5x 3606.HK's 20.83%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-1.33%
Share reduction while 3606.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-5.02%
Reduced diluted shares while 3606.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
120.51%
OCF growth 1.25-1.5x 3606.HK's 101.87%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
276.82%
Positive FCF growth while 3606.HK is negative. John Neff would see a strong competitive edge in net cash generation.
87778.82%
10Y revenue/share CAGR above 1.5x 3606.HK's 399.96%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
13.18%
5Y revenue/share CAGR under 50% of 3606.HK's 131.77%. Michael Burry would suspect a significant competitive gap or product weakness.
40.90%
3Y revenue/share CAGR 1.25-1.5x 3606.HK's 35.66%. Bruce Berkowitz might see better product or regional expansions than the competitor.
4300.92%
10Y OCF/share CAGR above 1.5x 3606.HK's 283.27%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1020.89%
OCF/share CAGR of 1020.89% while 3606.HK is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
4574.68%
3Y OCF/share CAGR of 4574.68% while 3606.HK is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
660.42%
Net income/share CAGR above 1.5x 3606.HK's 363.38% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-48.70%
Negative 5Y net income/share CAGR while 3606.HK is 413.84%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-43.92%
Negative 3Y CAGR while 3606.HK is 46.25%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
538.69%
5Y equity/share CAGR above 1.5x 3606.HK's 137.60%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
104.48%
3Y equity/share CAGR above 1.5x 3606.HK's 43.73%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-91.11%
Negative 5Y dividend/share CAGR while 3606.HK stands at 1774.09%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
46.46%
Our short-term dividend growth is positive while 3606.HK cut theirs. John Neff views it as a comparative advantage in shareholder returns.
3.48%
AR growth well above 3606.HK's 0.88%. Michael Burry fears inflated revenue or higher default risk in the near future.
21.91%
Inventory growth well above 3606.HK's 3.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.59%
Asset growth well under 50% of 3606.HK's 8.09%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
18.28%
BV/share growth above 1.5x 3606.HK's 8.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.26%
We’re deleveraging while 3606.HK stands at 32.18%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
314.74%
R&D growth of 314.74% while 3606.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
4.92%
We expand SG&A while 3606.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.